Anouncement: Doug London will be giving a lecture on Oct 1st, at 7 pm at the Plymouth library on Omega 3's and their use in treating Mental illness. Douglas S. London Douglas London is on the faculty of medicine at Harvard Medical School. London is a Research Associate at the Psychopharmacological Research Laboratory at Mclean Hospital and works with Andrew Stoll, MD, on novel treatments, particularly those that are most promising for developing nations and populations in the US that do not have access to traditional pharmacological medications and therapies. He is Executive Director of BrainRights for the Americas (Mente Sana para las Americas). He was director of the International Psychiatric Clinic (Clinica Internacional para la Ansiedad) in Antigua, Guatemala and is present director of the International Psychiatric Clinic in Honduras. He has worked for 15 years in developing nations in Africa and Latin America. London has worked for a variety of institutions including United States government programs, the United Nations, international non-governmental organizations and research institutions. He has established new hospitals in the developing world such as a general hospital in Angola, Africa, building the physical resources, training hospital staff and administering the hospital until it was running smoothly. London has also founded and served as director for a research mental health clinic in Central America. He has trained doctors and medical staff in aspects of psychopharmacology in hospitals in Central America. London has done research in psychopharmacology in the developing world including the use of omega-3 fatty acids in pediatric and adult affective disorder in Guatemala and is a pioneer in the field of agricultural psychiatry.